A comprehensive clinical guide to managing menopause symptoms after breast cancer, including hot flashes, vaginal dryness, and GSM, with evidence-based hormonal and non-hormonal treatment options for survivors.
A guide to diagnosing menopause and perimenopause, covering FSH and estradiol testing, symptom criteria, differential diagnosis from thyroid disease, and evidence-based treatment options including HRT, GSM care, and sleep strategies.
Why women gain weight during menopause and perimenopause, what hormones are responsible, and which treatments including HRT, GLP-1s, and lifestyle changes have the strongest clinical evidence.
A guide to oral micronized progesterone (Prometrium), its role alongside estradiol therapy, dosing schedules, sleep and cardiovascular benefits, and how patches, gels, sprays, and pills differ for menopausal women.
A comparison of oral and transdermal estradiol for menopausal HRT, covering VTE risk, liver metabolism, dosing, bioidentical options, patches vs gels, and how to choose based on your health profile.
A complete clinical guide to ospemifene (Osphena), the FDA-approved SERM for dyspareunia and vulvovaginal atrophy, with comparisons to estradiol patch, pill, gel, and spray options for menopausal women.
Progesterone and progestins protect the uterine lining during HRT, but they differ in molecular structure, side-effect profiles, cardiovascular risk, and breast-cancer signal. This guide covers the clinical evidence so you can have an informed conversation with your prescriber.
Genitourinary syndrome of menopause (GSM) affects over 50% of postmenopausal women, causing vaginal dryness, painful sex, and urinary symptoms. Learn what causes GSM, how it's diagnosed, and which treatments, from local estradiol to ospemifene, have the strongest clinical evidence.
Menopause-related mood swings, anxiety, and emotional upheaval are real, measurable, and treatable. Learn the neuroscience behind hormonal mood changes and the evidence-based solutions that work.
Yes, menopause causes fatigue through hormonal shifts, sleep disruption, mood changes, and thyroid interactions. Learn the mechanisms, timeframes, and evidence-based treatments that actually work.
Menopause can change body odor via lower estrogen, sweating, and pH shifts. Learn what helps: HRT, vaginal estrogen, antiperspirants, and lifestyle steps.
Estrogen directly regulates collagen synthesis, degradation, and skin thickness. Learn exactly how perimenopause-driven estrogen decline accelerates collagen loss, what the research shows, and what clinical options exist.
A guide to evidence-based options for menopause hot flashes, distinguishing FDA-approved treatments, off-label prescriptions, and lifestyle approaches, with a framework for matching severity to next steps.
Facial bone resorption accelerates during menopause as estrogen levels drop, reshaping the jaw, orbit, and midface. Learn the science, the evidence-backed treatments, and when to act.
Menopause belly and bloating are driven by estrogen decline, cortisol shifts, and gut microbiome changes. Learn the clinical causes and evidence-based relief strategies.
Perimenopause is the hormonal transition before menopause, lasting 2 to 10 years. Learn the symptoms, stages, hormone changes, and evidence-based treatment options prepared by the HealthRX.com Editorial Team.
Topical estrogen applied to the face may reduce wrinkles, restore skin thickness, and improve hydration during perimenopause and menopause. Learn the evidence, protocols, and risks prepared by the HealthRX.com Editorial Team.
Evidence-based guide to testosterone cream dosing for women, including vaginal estradiol cream dosing and PT-141 (bremelanotide) dosing. Learn recommended doses, application sites, monitoring, and safety considerations backed by clinical trials and guidelines.
A guide to the pharmacokinetic and pharmacodynamic interaction between trazodone and progesterone HRT, covering mechanism, severity, monitoring, dose adjustment, and patient counseling.
Learn how to access testosterone cypionate through FDA expanded access, compassionate use programs, PAPs, discount cards, and HSA/FSA accounts. 2025 guide.
A comparison of oral and vaginal estradiol for women's HRT, including which symptoms each treats best, when to switch, and how to manage treatment failure with evidence from WHI, Cochrane, and ACOG guidelines.
A guide to the clinical interaction between vaginal estradiol and SNRIs such as venlafaxine and duloxetine, covering mechanism, monitoring, dosing, and patient counseling.
A comparison of testosterone gel (AndroGel), cypionate, enanthate, propionate, and pellets. Includes doses, pharmacokinetics, side effects, and how to choose the right TRT formulation.
Veterans face unique low-testosterone risk factors including combat-related TBI, PTSD, opioid use, and chemical exposures. This guide covers VA eligibility, dosing protocols, age-specific considerations, and what the evidence actually shows.
A summary of the evidence for off-label use of oral micronized progesterone (Prometrium) in traumatic brain injury, including ProTECT III, SyNAPSe, GRADE ratings, and current clinical guidance.
How to store oral progesterone, read Prometrium temperature limits and expiry dates, and handle heat, moisture or damaged capsules.
A guide to every FDA label change for estradiol transdermal patches (Climara, Vivelle-Dot, Minivelle) from 2020 through 2026, with safety data, dosing tables, and practice implications.
Real-world estradiol patch outcomes at 12 months, synthesized from patient reviews and clinical trial data. Covers hot flash relief, sleep, mood, skin changes, and what to expect month by month.
See which FDA-approved manufacturers (Pfizer, Hikma) make testosterone cypionate, DEA quota limits, and the shortage history prescribers and patients should know.
A guide to testosterone enanthate missed-dose management, pharmacokinetics, injection timing, and how the drug works at the molecular level.
A clinician-level review of how testosterone enanthate affects depression, anxiety, cognition, and mood in hypogonadal men, with primary-literature citations, dosing context, and monitoring guidance.
A physician-level guide to diagnosing and resolving testosterone enanthate plateaus, including dose timing, injection technique, lab interpretation, and conversion strategies backed by primary literature.
A complete clinical guide to compounded T4/T3 combination thyroid therapy: how it compares with levothyroxine monotherapy, desiccated thyroid, and Cytomel, with dosing rationale, evidence, and safety data.
A clinical review of vaginal estradiol for genitourinary syndrome of menopause, examining what is established about pelvic floor tissue effects, what remains mechanistic or preliminary, and how formulation choice and physical therapy fit into a treatment plan.
A guide to using hormone replacement therapy (HRT) and GLP-1 receptor agonists together, covering dosing, safety, timing, and evidence-based protocols for perimenopause, postmenopause, and post-hysterectomy women.
How does HRT affect mammogram results, breast density, and breast cancer risk? A clinically detailed guide covering screening intervals, imaging choices, and what to tell your radiologist.
A clinical comparison of hormone replacement therapy versus antidepressants for hot flashes and night sweats, covering efficacy data, delivery routes, bioidentical vs synthetic options, and how to choose.
A comparison of topical (transdermal/vaginal) and oral micronized progesterone for HRT, covering absorption, endometrial protection, cardiovascular safety, sleep effects, and how to choose.
Hormone pellets are heavily marketed for perimenopause, but the FDA has not approved them and dosing is unpredictable. This guide covers the clinical evidence, risks, and safer alternatives so you can make an informed decision.
A direct comparison of the estradiol transdermal patch and oral micronized progesterone (Prometrium) side-effect profiles, using WHI, PEPI, and current NAMS/Endocrine Society guidelines to help patients and clinicians choose the right HRT formulation.
A clinician-level review of the estradiol transdermal patch and prednisone drug interaction, covering mechanism, severity, monitoring parameters, and patient counseling for safe co-administration.
Modafinil (Provigil) induces CYP3A4, which metabolizes progesterone. Learn how this interaction reduces hormone levels, what clinical monitoring looks like, and how prescribers manage the combination safely.
A breakdown of the pharmacokinetic and pharmacodynamic interactions between testosterone cypionate and hormonal contraceptives, including monitoring parameters, dose considerations, and patient counseling points.
A guide to the pharmacokinetic and pharmacodynamic interaction between zoledronic acid (Reclast) and estradiol HRT, covering safety, monitoring, VTE risk, and dosing guidance.
Everything you need to know about traveling with an estradiol transdermal patch, storage temperatures, TSA rules, time-zone dosing, and sweat or water exposure, prepared by the HealthRX.com Editorial Team.
How oral micronized progesterone (Prometrium) affects sleep quality, why bedtime dosing matters, and evidence-based strategies to get the most from your nightly dose.
A guide to TRT for men, covering benefits, side effects, cardiovascular safety, diabetes, BPH, prostate surgery, and how to get started safely.
Free testosterone and total testosterone measure different things. Learn what SHBG does, why bioavailable T matters more than total T on most lab reports, and how HPG axis suppression affects both numbers.
Can oral estradiol improve mood? A detailed look at the off-label evidence, FDA-approved context, GRADE ratings, dosing signals, and monitoring requirements for mood-related prescribing.
A look at whether oral micronized progesterone (Prometrium) has a role in traumatic brain injury treatment, what the clinical trials found, and the risks patients and providers should weigh.
A detailed look at how often the estradiol transdermal patch works in real-world use, combining clinical trial data, FDA labeling, and patient-reported outcomes from Reddit and verified review platforms.
A real clinical protocol for assessing, preventing, and managing accidental testosterone transfer from AndroGel to female partners and children, including escalation criteria and signs of virilization.
A clinical deep-dive into pharmacological and procedural strategies for managing accidental testosterone transfer from AndroGel to women and children, including first-line interventions, anti-androgen options, and dose ranges.
How often does AndroGel testosterone transfer to partners and children, how serious is it, and what actually stops it? Evidence-anchored incidence data, severity grading, and step-by-step prevention for patients and prescribers.
Secondary testosterone exposure from AndroGel can cause lasting virilization in women and children. Learn the mechanism, warning signs, management steps, and when to seek urgent care.
Real titration protocols for managing inconsistent serum testosterone from AndroGel: when to slow the schedule, pause, step down, or microdose, plus when none of those strategies work.
A clinical deep-dive into why AndroGel produces inconsistent serum testosterone levels, covering skin barrier pharmacology, application-site differences, inter-patient variability, and practical steps to stabilize absorption.
Clinically specific guide to OTC and prescription interventions for inconsistent AndroGel absorption, including dose ranges, application protocols, and what to avoid.
Exact clinical thresholds, lab criteria, quality-of-life benchmarks, and switch options for patients and prescribers deciding whether inconsistent AndroGel absorption warrants discontinuation.
A clinical-grade explanation of how transdermal estradiol stimulates ductal breast tissue to cause tenderness, plus real-time management strategies for patients and prescribers.